These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2575972)

  • 1. [Changes in humoral substances in induced cirrhosis and their effects on portal hemodynamics].
    Li XN
    Zhonghua Wai Ke Za Zhi; 1989 Aug; 27(8):489-94, 510. PubMed ID: 2575972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of blood humoral substances in experimental cirrhosis and their effects on portal hemodynamics.
    Li XN; Huang CT; Wang XH; Leng XS; Du RY; Chen YF; Hou X
    Chin Med J (Engl); 1990 Dec; 103(12):970-7. PubMed ID: 2127249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
    Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
    J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splanchnic haemodynamics and vasoactive agents in experimental cirrhosis.
    Geraghty JG; Angerson WJ; Carter DC
    HPB Surg; 1994; 8(2):83-7; discussion 87-8. PubMed ID: 7880777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral substances in peripheral and portal veins in cirrhotic patients].
    Li SJ; Wang XH; Han JD
    Zhonghua Wai Ke Za Zhi; 1988 Jan; 26(1):44-7, 62. PubMed ID: 2904350
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic hemodynamics and functions in extrahepatic portal obstruction in the rat with liver cirrhosis.
    Omokawa S; Saitoh H; Arai Y; Itoh M; Furuya T; Asanuma Y; Koyama K
    Hepatogastroenterology; 1991 Feb; 38(1):56-9. PubMed ID: 2026390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide in cirrhotic rats: hemodynamic effects and mesenteric arterial receptor characteristics.
    Lee SS; Huang M; Ma Z; Rorstad O
    Hepatology; 1996 May; 23(5):1174-80. PubMed ID: 8621151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
    Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
    Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vasoactive substances in hyperhemodynamics after orthotopic liver transplantation in cirrhotic rats.
    Cao H; Wu Z; Zhang X; Zhang H; Chen Z; Kuang Y
    Chin Med J (Engl); 2003 Mar; 116(3):405-9. PubMed ID: 12781047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations to hepatic microcirculation in thioacetamide-induced cirrhotic livers of rats.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ogami M; Yamada R
    Osaka City Med J; 2002 Jun; 48(1):1-8. PubMed ID: 12375692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis.
    Moreau R; Oberti F; Lahaye P; Gadano A; Cailmail S; Sogni P; Cales P; Lebrec D
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1254-8. PubMed ID: 9918435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of side-to-side mesocaval shunt, pericardial devascularization, and a combined procedure in cirrhotic rats].
    Zhang FX
    Zhonghua Wai Ke Za Zhi; 1990 Mar; 28(3):151-4, 189. PubMed ID: 2379425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance.
    Rockey DC; Weisiger RA
    Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological lowering of portal pressure in normal rats and in experimental liver cirrhosis].
    Altmann O
    Gastroenterol J; 1991; 51(3-4):142-8. PubMed ID: 1811660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat.
    Barrowman JA; Granger DN
    Gastroenterology; 1984 Jul; 87(1):165-72. PubMed ID: 6724260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterialization of the portal vein improves hepatic microcirculation and tissue oxygenation in experimental cirrhosis.
    Yang W; Koti R; Glantzounis G; Davidson BR; Seifalian AM
    Br J Surg; 2003 Oct; 90(10):1232-9. PubMed ID: 14515292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of hepatic pathologic changes and portal venous pressure in the course of cirrhosis in rats].
    Wu ZY
    Zhonghua Wai Ke Za Zhi; 1990 Mar; 28(3):147-50, 189. PubMed ID: 2379424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.